News - Jul 3, 2026
ElevenLabs Now Clones Your Voice in Real Time
ElevenLabs has added real-time voice cloning to its platform, meaning your cloned voice can now be used during live audio — not just in pre-rendered outputs. Previously, voice cloning on ElevenLabs worked for generated audio files only. You'd upload samples, create a clone, and export finished audio. Now, the cloned voice works with latency low enough for live use cases: live streaming, real-time dubbing, and voice-powered applications built on their API. The feature is available to Creator tier subscribers and above, which starts at $22 per month. Free and Starter tier users do not get access. API access for developers building real-time voice applications requires a paid plan, and usage is metered on top of the subscription cost. This is not a minor tweak — real-time cloning is technically harder than batch cloning and opens up entirely different use cases, including live customer service bots, real-time translation with a user's own voice, and interactive media. It also raises the obvious concern: live voice cloning is a more immediate fraud and impersonation vector than file-based cloning, and ElevenLabs' existing safeguards — consent verification, voice rights agreements — have never been independently audited for real-world effectiveness.
What changed
Voice cloning moved from file-output-only to real-time, live audio. Available on Creator plan ($22/month) and above. API access is metered separately on top of subscription fees.
Who this affects
Developers building voice AI apps, live streamers, dubbing professionals, and anyone needing a cloned voice in live contexts benefit. Free and Starter users are locked out entirely.
Our take
Real-time voice cloning is genuinely useful and genuinely dangerous, and ElevenLabs asking users to self-certify consent is not the same as actually enforcing it.
Based on ElevenLabs platform announcements and published pricing tiers. Independent audit of safety measures has not been conducted.
VerdictBloom is editorially independent. No company reviewed or approved this article before publication.